throbber
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`INNOPHARMA LICENSING, INC., INNOPHARMA LICENSING LLC,
`INNOPHARMA INC., INNOPHARMA LLC,
`MYLAN PHARMACEUTICALS INC., MYLAN INC., LUPIN LTD. and LUPIN
`PHARMACEUTICALS INC.
`Petitioner,
`
`v.
`
`SENJU PHARMACEUTICAL CO., LTD., BAUSCH & LOMB, INC., and
`BAUSCH & LOMB PHARMA HOLDINGS CORP.
`Patent Owner.
`
`
`
`Case IPR2015-00902 (Patent 8,669,290 B2)
` Case IPR2015-00903 (Patent 8,129,431 B2)1
`
`
`
`Filed: March 18, 2016
`
`PETITIONER’S MOTION TO SEAL
`
`
`1 A word-for-word identical paper has been filed in each proceeding identified in
`
`the heading. IPR2015-01871 has been joined with IPR2015-00903 and includes
`
`Petitioners Lupin Ltd. and Lupin Pharmaceuticals Inc. in addition to the parties
`
`identified above.
`
`
`
`

`
`
`
`Pursuant to 37 C.F.R. §§ 42.14 and 42.55 and the Protective Order (Paper
`
`36) entered in this proceeding, Petitioner hereby moves to seal the following
`
`categories of exhibits:
`
`(1) deposition transcripts designated by Patent Owner as containing
`
`confidential information under the Proposed Stipulated Protective Order
`
`(Paper 36 in IPR2015-00902; Paper 38 in IPR2015-00903) (“Proposed
`
`Stipulated Protective Order”);
`
`(2) documents from a concurrent district court proceeding before the
`
`United States District Court for the District of New Jersey in Senju
`
`Pharmaceutical Co., Ltd. et al. v. InnoPharma Licensing, Inc. et al., C.A.
`
`No. 1:14-cv-06893-JBS-KMW
`
`(D.N.J.
`
`filed Nov. 3, 2014) and
`
`corresponding cases designated by Patent Owner as Confidential pursuant to
`
`the Discovery Confidentiality Order (ECF No. 28 para. 11; see also Senju et
`
`al. v. Lupin et al., C.A. 14:-cv-00667 (D.N.J.) ECF 34) (“Discovery
`
`Confidentiality Order”); and
`
`(3) Petitioners’ Replies, the Declaration of Ivan Hoffmann, and the
`
`Declaration of Dr. Paul Laskar filed concurrently herewith in IPR2015-
`
`00902 and IPR2015-00902, which contain or refer to information contained
`
`in the aforementioned transcripts designated confidential by the Patent
`
`Owner, documents designated as Protective Order Material Confidential
`
`
`
`1
`
`

`
`
`
`under the Proposed Stipulated Protective Order by the Patent Owner,
`
`documents designated as Confidential under the Discovery Confidentiality
`
`Order by the Patent Owner, or testimony designated as Protective Order
`
`Material - Fed. R. Evid. 615 under the Proposed Stipulated Protective Order
`
`by the Patent Owner.
`
`The record of an inter partes review proceeding, including documents and
`
`things, is made available to the public, except as otherwise ordered. 37 C.F.R. §
`
`42.14. Despite the default rule of public availability, the Board will seal
`
`confidential information for “good cause,” because it is necessary to “strike a
`
`balance between
`
`the public’s
`
`interest
`
`in maintaining a complete and
`
`understandable file history and the parties’ interest in protecting truly sensitive
`
`information.” 37 C.F.R. § 42.54(a); 77 Fed. Reg. 48756, 48760 (Aug. 14, 2012).
`
`It is Petitioner’s understanding that information in the following documents
`
`has been designated as confidential to Patent Owner, pursuant to the Proposed
`
`Stipulated Protective Order:
`
`•
`
`•
`
`
`
`Portions of EX1083 (Myers Transcript), 141:9-203:10.
`
`Portions of EX1082 (Paulson Transcript), 71:13-74:11, 105:13-106:13,
`
`107:4-11, 108:19-109:4, 109:11-16, 113:1-7, 113:16-116:22, 118:7-123:14,
`
`124:11-22, 125:5-6, 125:12-20, 126:2-8, 126:12-22, 127:6-128:3, 128:17-19,
`
`131:5-132:6, 132:9, 132:12-133:21, 134:8-135:1, 137-142:12, 143:21-144:1,
`
`2
`
`

`
`
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`•
`
`
`
`144:7-22, 145:14-146:7, 146:13-15, 146:19-147:9, 147:15-22, 148:12-18,
`
`149:3-7, 149:12-14, 149:17-151:19, 152:15-153:4, 156:10-157:12, 159:7-
`
`160:9, 170:19-172:7, 180:9-12, 181:13-19, 182:6-183:9, 183:19-184:19,
`
`187:13-188:15, 191:16-312:10.
`
`Portions of EX1081 (Trattler Transcript), 111:10-12.
`
`Portions of EX1079 (Williams Transcript), 121:5-18, 122:7-20, 123:1-
`
`125:16, 126:4-127:2.
`
`Portions of EX1049 (Jarosz Transcript), 8:17-18, 9:5-8, 97:5-98:16, 107:7-
`
`111:11.
`
`Portions of EX1150 (Hofmann Declaration)
`
`Portions of EX1104 (Laskar Declaration)
`
`Portions of Petitioner’s Reply to Patent Owner’s Response
`
`The entirety of EX1067, EX1117, EX1134, EX1140, and EX1152
`
`3
`
`

`
`
`
`Patent Owner has requested that Petitioner file these documents under seal
`
`and file an appropriate motion to seal under the Proposed Stipulated Protective
`
`Order. (See Appendix A and Appendix B attached hereto). Petitioner has no
`
`independent basis for the aforementioned documents to be sealed and thus makes
`
`no assertion as to whether or not they contain confidential information. Patent
`
`RESPECTFULLY SUBMITTED,
`
`ALSTON & BIRD LLP
`
`
`
`
`
`
`
`/Jitendra Malik/
`
`Jitendra Malik (Reg. No. 55823)
`Reg. No. 55823
`Alston & Bird LLP
`4721 Emperor Blvd., Suite 400
`Durham, NC 27703-8580
`jitty.malik@alston.com
`
`Lead Counsel for Petitioner
`
`
`4
`
`owner does not oppose this motion.
`
`
`
`Date: March 18, 2015
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`
`
`
`CERTIFICATION OF SERVICE
`
`Pursuant to 37 C.F.R. §§ 42.6(e), 42.8(b)(4) and 42.105, the undersigned
`
`certifies that on the 18th day of March, 2016, a complete copy of the foregoing
`
`Petitioner’s Motion to Seal was served on counsel of record for the Patent Owner:
`
`Senju Pharmaceutical Co., Ltd., et al.
`
`Bryan C. Diner
`bryan.diner@finnegan.com
`
`Justin J. Hasford
`justin.hasford@finnegan.com
`
`Joshua L. Goldberg
`Joshua.goldberg@finnegan.com
`
`
`
`
`
`Respectfully submitted,
`
`Alston & Bird LLP
`
`By: /Jitendra Malik/
`
`Jitendra Malik, Ph.D.
`Reg. No. 55823
`Alston & Bird LLP
`4721 Emperor Blvd., Suite 400
`Durham, NC 27703-8580
`jitty.malik@alston.com
`
`Bryan Skelton, Ph.D.
`Reg. No. 50893
`Alston & Bird LLP
`4721 Emperor Blvd., Suite 400
`Durham, NC 27703-8580
`bryan.skelton@alston.com
`
`1
`
`

`
`
`Lance Soderstrom
`Reg. No. 65405
`Alston & Bird LLP
`90 Park Avenue
`15th Floor
`New York, NY 10016-1387
`lance.soderstrom@alston.com
`
`Hidetada James Abe
`Reg. No. 61,182
`Alston & Bird LLP
`333 South Hope Street
`16th Floor
`Los Angeles, CA 90071
`james.abe@alston.com
`
`Joseph M. Janusz
`Reg. No. 70396
`ALSTON & BIRD LLP
`101 S. Tryon Street, Suite 4000
`Charlotte, NC 28205
`Telephone: 704-444-1000
`Fax: 704-444-1111
`joe.janusz@alston.com
`
`Attorneys for Petitioners InnoPharma
`Licensing, Inc., InnoPharma Licensing
`LLC, InnoPharma Inc., InnoPharma
`LLC, Mylan Pharmaceuticals Inc., and
`Mylan Inc.
`
`
`
`Deborah H. Yellin (Reg. No. 45,904)
`Crowell & Moring LLP
`Intellectual Property Group
`1001 Pennsylvania Avenue, N.W.
`Washington, DC 20004-2595
`Telephone No.: (202) 624-2947
`Facsimile No.: (202) 628-5116
`
`2
`
`
`
`

`
`
`
`
`
`DYellin@Crowell.com
`
`Jonathan Lindsay (Reg. No. 45,810)
`Crowell & Moring LLP
`Intellectual Property Group
`3 Park Plaza, 20th Floor
`Irvine, CA 92614-8505
`Telephone No.: (949) 798-1325
`Facsimile No.: (949) 263-8414
`JLindsay@Crowell.com
`
`Attorneys for Petitioners Lupin Ltd. and
`Lupin Pharmaceuticals, Inc.
`
`
`3
`
`

`
`Appendix A
`Appendix A
`
`
`
`IPR2015-00902
`IPR2015-00902
`IPR2015-00903
`IPR2015-00903
`
`
`
`
`
`

`
`Elizabeth D. Ferrill
`Attorney at Law
`Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
`901 New York Avenue, NW, Washington, DC 20001-4413
`202.408.4445 | fax: 202.408.4400 | elizabeth.ferrill@finnegan.com | www.finnegan.com
`
`

`
`
`
`
`
`This e-mail message is intended only for individual(s) to whom it is addressed and may contain information that is privileged, confidential, proprietary, or otherwise
`exempt from disclosure under applicable law. If you believe you have received this message in error, please advise the sender by return e-mail and delete it from
`your mailbox. Thank you.
`
`

`
`Appendix B
`Appendix B
`
`
`
`IPR2015-00902
`IPR2015-00902
`IPR2015-00903
`IPR2015-00903
`
`
`
`
`
`

`
`Elizabeth D. Ferrill
`Attorney at Law
`Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
`901 New York Avenue, NW, Washington, DC 20001-4413
`202.408.4445 | fax: 202.408.4400 | elizabeth.ferrill@finnegan.com | www.finnegan.com
`
`

`
`H. James Abe
`Alston & Bird LLP
`333 S. Hope Street, 16th Floor, Los Angeles, California 90071
`direct: 213-576-1060 | fax: 213-576-1100 | cell: 714-209-3505
`james.abe@alston.com | www.alston.com
`
`H. James Abe
`
`

`
`Alston & Bird LLP
`333 S. Hope Street, 16th Floor, Los Angeles, California 90071
`direct: 213-576-1060 | fax: 213-576-1100 | cell: 714-209-3505
`james.abe@alston.com | www.alston.com
`
`
`
`
`
`This e-mail message is intended only for individual(s) to whom it is addressed and may contain information that is privileged, confidential, proprietary, or otherwise
`exempt from disclosure under applicable law. If you believe you have received this message in error, please advise the sender by return e-mail and delete it from
`your mailbox. Thank you.

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket